BAD-729

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameBAD-729
Drug Alias NameModulinmRNA modulator (Novation)benzoic acid derivative (Novation)BAD-729
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein modulatorsApoptosis regulator Bcl-2 modulators
TargetsApoptosis regulator Bcl-2Myc proto-oncogene protein
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovation Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A